FDA — authorised 7 April 1967
- Status: approved
🇺🇸 Bovizole in United States
FDA authorised Bovizole on 7 April 1967
Marketing authorisations
FDA — authorised 7 April 1967
- Application: NDA016096
- Marketing authorisation holder: MERCK SHARP DOHME
- Local brand name: MINTEZOL
- Indication: TABLET, CHEWABLE — ORAL
- Status: approved
FDA — authorised 21 April 1967
- Application: NDA016097
- Marketing authorisation holder: MERCK SHARP DOHME
- Local brand name: MINTEZOL
- Indication: SUSPENSION — ORAL
- Status: approved
Bovizole in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Bovizole approved in United States?
Yes. FDA authorised it on 7 April 1967; FDA authorised it on 7 April 1967; FDA authorised it on 21 April 1967.
Who is the marketing authorisation holder for Bovizole in United States?
Marketing authorisation holder not available in our data.